Nostrum Laboratories, Inc. recalls Sucralfate Tablets
- Published
- 6 Aug 2025
- Units affected
- 60,608 bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.
- Brand / company
- Nostrum Laboratories, Inc.
- Codes / lots
- All Lots within expiry dates.
- Distribution
- nationwide within the United States
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 6 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.